Identification of functional lipid metabolism biomarkers of brown adipose tissue aging.


Journal

Molecular metabolism
ISSN: 2212-8778
Titre abrégé: Mol Metab
Pays: Germany
ID NLM: 101605730

Informations de publication

Date de publication:
06 2019
Historique:
received: 10 12 2018
revised: 22 03 2019
accepted: 28 03 2019
pubmed: 21 4 2019
medline: 16 4 2020
entrez: 21 4 2019
Statut: ppublish

Résumé

Aging is accompanied by loss of brown adipocytes and a decline in their thermogenic potential, which may exacerbate the development of adiposity and other metabolic disorders. Presently, only limited evidence exists describing the molecular alterations leading to impaired brown adipogenesis with aging and the contribution of these processes to changes of systemic energy metabolism. Samples of young and aged murine brown and white adipose tissue were used to compare age-related changes of brown adipogenic gene expression and thermogenesis-related lipid mobilization. To identify potential markers of brown adipose tissue aging, non-targeted proteomic and metabolomic as well as targeted lipid analyses were conducted on young and aged tissue samples. Subsequently, the effects of several candidate lipid classes on brown adipocyte function were examined. Corroborating previous reports of reduced expression of uncoupling protein-1, we observe impaired signaling required for lipid mobilization in aged brown fat after adrenergic stimulation. Omics analyses additionally confirm the age-related impairment of lipid homeostasis and reveal the accumulation of specific lipid classes, including certain sphingolipids, ceramides, and dolichols in aged brown fat. While ceramides as well as enzymes of dolichol metabolism inhibit brown adipogenesis, inhibition of sphingosine 1-phosphate receptor 2 induces brown adipocyte differentiation. Our functional analyses show that changes in specific lipid species, as observed during aging, may contribute to reduced thermogenic potential. They thus uncover potential biomarkers of aging as well as molecular mechanisms that could contribute to the degradation of brown adipocytes, thereby providing potential treatment strategies of age-related metabolic conditions.

Identifiants

pubmed: 31003944
pii: S2212-8778(18)31191-8
doi: 10.1016/j.molmet.2019.03.011
pmc: PMC6531832
pii:
doi:

Substances chimiques

Biomarkers 0
Ceramides 0
Dolichols 0
Proteome 0
Sphingolipids 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1-17

Informations de copyright

Copyright © 2019 The Authors. Published by Elsevier GmbH.. All rights reserved.

Références

Front Biosci (Landmark Ed). 2011 Jan 01;16:1233-60
pubmed: 21196229
Nat Med. 2017 May;23(5):631-637
pubmed: 28346411
Am J Epidemiol. 2005 Aug 15;162(4):373-81
pubmed: 16014782
Nat Protoc. 2009;4(1):44-57
pubmed: 19131956
Cancer Res. 2017 Nov 1;77(21):5963-5976
pubmed: 28883000
J Bioenerg Biomembr. 1999 Oct;31(5):507-16
pubmed: 10653478
Clin Chim Acta. 2006 Jun;368(1-2):1-19
pubmed: 16480697
Metabolism. 1995 Feb;44(2):239-44
pubmed: 7869922
Diabetes. 2009 Jul;58(7):1526-31
pubmed: 19401428
Nutrients. 2016 Mar 02;8(3):128
pubmed: 26950145
Methods Mol Biol. 2017;1566:25-36
pubmed: 28244038
J Gerontol A Biol Sci Med Sci. 2005 Jan;60(1):39-43
pubmed: 15741281
Am J Physiol Endocrinol Metab. 2011 Jan;300(1):E211-20
pubmed: 20959533
BMC Bioinformatics. 2013 Apr 15;14:128
pubmed: 23586463
Biochim Biophys Acta. 1999 Jan 6;1426(2):239-57
pubmed: 9878760
Physiol Rev. 1998 Apr;78(2):339-58
pubmed: 9562032
Am J Physiol Cell Physiol. 2000 Sep;279(3):C670-81
pubmed: 10942717
Nat Cell Biol. 2005 Jun;7(6):601-11
pubmed: 15895078
Ther Drug Monit. 2005 Dec;27(6):747-51
pubmed: 16404815
Proc Natl Acad Sci U S A. 2011 Jan 4;108(1):143-8
pubmed: 21173238
Lipids. 1990 Oct;25(10):586-93
pubmed: 1964191
Aging Cell. 2017 Jun;16(3):529-540
pubmed: 28139067
Cell. 2016 Mar 24;165(1):125-138
pubmed: 27015310
Cell Metab. 2018 Jul 03;28(1):159-174.e11
pubmed: 29861389
J Membr Biol. 2011 Nov;244(2):97-103
pubmed: 22052236
J Biol Chem. 2003 Mar 28;278(13):11312-9
pubmed: 12496283
J Clin Invest. 2006 Nov;116(11):3015-25
pubmed: 17053832
Methods Mol Biol. 2001;155:295-303
pubmed: 11293080
Am J Physiol. 1998 Jan;274(1):R196-203
pubmed: 9458918
Nat Rev Mol Cell Biol. 2003 May;4(5):397-407
pubmed: 12728273
Aging Cell. 2012 Dec;11(6):1074-83
pubmed: 23020201
Nat Commun. 2016 Mar 09;7:10895
pubmed: 26955961
Biochim Biophys Acta. 1996 Oct 18;1303(3):169-79
pubmed: 8908150
Diabetes. 2005 Mar;54(3):591-602
pubmed: 15734832
Lipids. 2003 Nov;38(11):1133-42
pubmed: 14733358
J Proteome Res. 2010 Aug 6;9(8):4113-22
pubmed: 20568816
PLoS One. 2011;6(7):e21800
pubmed: 21789182
Handb Exp Pharmacol. 2019;251:183-214
pubmed: 30141101
Nucleic Acids Res. 2015 Jul 1;43(W1):W566-70
pubmed: 25969447
Int J Mol Med. 2016 Oct;38(4):1030-8
pubmed: 27600830
Lipids. 1989 Jul;24(7):579-84
pubmed: 2779364
PLoS Comput Biol. 2007 Feb 23;3(2):e34
pubmed: 17319738
J Gerontol A Biol Sci Med Sci. 2018 Aug 10;73(9):1139-1146
pubmed: 29668887
Biochim Biophys Acta. 1992 Jan 31;1103(2):324-6
pubmed: 1543717
J Biol Chem. 2010 Mar 5;285(10):7153-64
pubmed: 20028987
Adipocyte. 2014 Apr 1;3(2):121-5
pubmed: 24719785
Coron Artery Dis. 2013 Dec;24(8):642-50
pubmed: 24212262
Am J Physiol Endocrinol Metab. 2007 Aug;293(2):E444-52
pubmed: 17473055
Cell Metab. 2016 Dec 13;24(6):820-834
pubmed: 27818258
J Lipid Res. 2013 Sep;54(9):2325-40
pubmed: 23821742
Cell Metab. 2007 Mar;5(3):167-79
pubmed: 17339025
Nucleic Acids Res. 2016 Jul 8;44(W1):W90-7
pubmed: 27141961
J Neurochem. 1990 Mar;54(3):855-62
pubmed: 2154552
Proc Natl Acad Sci U S A. 2014 Jul 1;111(26):9597-602
pubmed: 24979806
Cell Metab. 2014 Oct 7;20(4):678-86
pubmed: 25295788
N Engl J Med. 2009 Apr 9;360(15):1509-17
pubmed: 19357406
Nucleic Acids Res. 2007 Jan;35(Database issue):D527-32
pubmed: 17098933
J Am Geriatr Soc. 1984 Mar;32(3):219-28
pubmed: 6321584
Int J Mol Sci. 2018 Dec 11;19(12):
pubmed: 30545025
Anal Chem. 2009 Aug 1;81(15):6546-51
pubmed: 19588932
Cell Rep. 2018 Jul 17;24(3):781-790
pubmed: 30021173
Biochem J. 1996 Mar 15;314 ( Pt 3):761-8
pubmed: 8615767

Auteurs

Sabrina Gohlke (S)

Department of Adipocyte Development and Nutrition, German Institute of Human Nutrition Potsdam-Rehbrücke, Nuthetal, Germany.

Vyacheslav Zagoriy (V)

metaSysX GmbH Potsdam Golm, Germany.

Alvaro Cuadros Inostroza (A)

metaSysX GmbH Potsdam Golm, Germany.

Michaël Méret (M)

metaSysX GmbH Potsdam Golm, Germany.

Carola Mancini (C)

Department of Adipocyte Development and Nutrition, German Institute of Human Nutrition Potsdam-Rehbrücke, Nuthetal, Germany.

Lukasz Japtok (L)

Department of Toxicology, Institute of Nutritional Science, University of Potsdam, Potsdam-Rehbrücke, Nuthetal, Germany.

Fabian Schumacher (F)

Department of Toxicology, Institute of Nutritional Science, University of Potsdam, Potsdam-Rehbrücke, Nuthetal, Germany; Department of Molecular Biology, University of Duisburg-Essen, Essen, Germany.

Doreen Kuhlow (D)

Department of Adipocyte Development and Nutrition, German Institute of Human Nutrition Potsdam-Rehbrücke, Nuthetal, Germany.

Antonia Graja (A)

Department of Adipocyte Development and Nutrition, German Institute of Human Nutrition Potsdam-Rehbrücke, Nuthetal, Germany.

Heike Stephanowitz (H)

Leibniz Institute for Molecular Pharmacology, Berlin, Germany.

Markus Jähnert (M)

Department of Experimental Diabetology, German Institute of Human Nutrition Potsdam-Rehbrücke, Nuthetal, Germany; German Center for Diabetes Research (DZD), München, Neuherberg, Germany.

Eberhard Krause (E)

Leibniz Institute for Molecular Pharmacology, Berlin, Germany.

Andreas Wernitz (A)

Department of Molecular Epidemiology, German Institute of Human Nutrition Potsdam-Rehbrücke, Nuthetal, Germany.

Klaus-Jürgen Petzke (KJ)

Department of Molecular Epidemiology, German Institute of Human Nutrition Potsdam-Rehbrücke, Nuthetal, Germany.

Annette Schürmann (A)

Department of Experimental Diabetology, German Institute of Human Nutrition Potsdam-Rehbrücke, Nuthetal, Germany; German Center for Diabetes Research (DZD), München, Neuherberg, Germany.

Burkhard Kleuser (B)

Department of Toxicology, Institute of Nutritional Science, University of Potsdam, Potsdam-Rehbrücke, Nuthetal, Germany; NutriAct - Competence Cluster Nutrition Research, Berlin, Potsdam, Germany.

Tim J Schulz (TJ)

Department of Adipocyte Development and Nutrition, German Institute of Human Nutrition Potsdam-Rehbrücke, Nuthetal, Germany; German Center for Diabetes Research (DZD), München, Neuherberg, Germany; Institute of Nutritional Science, University of Potsdam, Potsdam-Rehbrücke, Nuthetal, Germany. Electronic address: tim.schulz@dife.de.

Articles similaires

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male
Humans Meals Time Factors Female Adult

Classifications MeSH